The present disclosure provides methods of treating liver cancer and preventing liver cancer recurrence with anti-progastrin antibodies, methods of monitoring treatment efficacy of anti-progastrin therapy for liver cancer, and compositions useful therefore.
申请公布号
CA2806157(A1)
申请公布日期
2012.02.02
申请号
CA20112806157
申请日期
2011.07.22
申请人
LES LABORATOIRES SERVIER;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)